2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow ZYIL1: new trials by email Literature Review of ZYIL1 trials Research Report on ZYIL1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis ZYIL1 capsules 25 mg and 50 mg Placebo, ZYIL1 capsules 50 mg and 25 mg Placebo, ZYIL1 capsules 25 mg and ZYIL1 capsules 50 mg - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | Zydus Lifesciences Limited | 24 | 2023-11-09 | 2024-12-19 |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) ZYIL1 capsule - Cryopyrin Associated Periodic Syndrome | Phase 2 | Completed | Zydus Lifesciences Limited | 3 | 2022-06-01 | 2022-07-11 |
Amyotrophic Lateral Sclerosis (1) · Cryopyrin-Associated Periodic Syndromes (1)
Zydus Lifesciences Limited (2)
Australia (1) · India (1)
Dr Deven Parmar, MD (1) · Dr. Deven Parmar, MD,FCP (1)